albiglutide + insulin glargine
108486
Phase 3 mab completed
Quick answer
albiglutide + insulin glargine for Diabetes Mellitus, Type 2 is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 3
- Modality
- mab
- Status
- completed